Effects of transferred NK4 gene on proliferation, migration, invasion and apoptosis of human prostate cancer DU145 cells

Asian Journal of Andrology

Volumn 12, Issue 3, 2010, Pages 381-389

  Yue, Dan ^a   Wang, Yong ^a   Ma, Ping ^a   Li, Yin Yan ^a   Chen, Hong ^a   Wang, Ping ^a   Ren, Chang Shan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

DU145 cells; Hepatocyte growth factor; Human prostate cancer; NK4

Indexed keywords

COMPLEMENTARY DNA; ENHANCED GREEN FLUORESCENT PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 3; ONCOPROTEIN; PROTEIN KINASE B; PROTEIN KINASE B 1; PROTEIN KINASE B 2; PROTEIN NK4; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CANCER CELL; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA MODIFICATION; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; TUMOR GROWTH;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; AUTOCRINE COMMUNICATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TRANSFER, HORIZONTAL; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77952026058     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2010.22     Document Type: Article

References (18)

1. Matsumoto K, Nakamura T. NK4 gene therapy targeting HGF-Met and angiogenesis. Front Biosci 2008;13:1943-51.
2. Nakashiro K, Hayashi Y, Oyasu R. Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue. Oncol Rep 2003;10:1149-53.
3. Hashem M, Essam T. hepatocyte growth factor as a tumor marker in the serum of patients with prostate cancer. J Egypt Natl Canc Inst 2005;17:114-20.
4. Yasuda K, Nagakawa O, Akashi T, Fujiuchi Y, Koizumi K, et al. Serum active hepatocyte growth factor (AHGF) in benign prostatic disease and prostate cancer. Prostate 2009;69:346-51.
5. Nakashiro K, Hara S, Shinohara Y, Oyasu M, Kawamata H, et al. Phenotypic switch from paracrine to autocrine role of hepatocyte growth factor in an androgen-independent human prostatic carcinoma cell line, CWR22R. Am J Pathol 2004;165:533-40.
6. Humphrey PA, Zhu X, Zarnegar R, Swanson PE, Ratliff TL, et al. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. Am J Pathol 1995;147:386-96.
7. du W, Hattori Y, Yamada T, Matsumoto K, Nakamura T, et al. NK4, an antagonist of hepatocyte growth factor (HGF), inhibits growth of multiple myeloma cells: molecular targeting of angiogenic growth factor. Blood 2007;109:3042-9.
8. Murakami M, Nagai E, Mizumoto K, Saimura M, Ohuchida K, et al. Suppression of metastasis of human pancreatic cancer to the liver by transportal injection of recombinant ad-enoviral NK4 in nude mice. Int J Cancer 2005;117:160-5.
9. Wright TG, Singh VK, Li JJ, Foley JH, Miller F, et al. Increased production and secretion of HGF alpha-chain and an antagonistic HGF fragment in a human breast cancer progression model. Int J Cancer 2009;125:1004-15.
10. Yue D, Wang Y, Xiao JY, Wang P, Ren CS. Expression of TRPC6 in benign and malignant human prostate tissues. Asian J Androl 2009;11:541-7.
11. Davies G, Watkins G, Mason MD, Jiang WG. Targeting the HGF/SF receptor c-met using a hammerhead ribozyme transgene reduces in vitro invasion and migration in prostate cancer cells. Prostate 2004;60:317-24.
12. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003;4:915-25.
13. Kuba K, Matsumoto K, Date K, Shimura H, Tanaka M, et al. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res 2000;60:6737-43.
14. Legrand V, Leissner P, Winter A, Mehtali M, Lusky M. Transductional targeting with recombinant adenovirus vectors. Curr Gene Ther 2002;2:323-39.
15. Dorer DE, Nettelbeck DM. Targeting cancer by transcrip-tional control in cancer gene therapy and viral oncolysis. Adv Drug Deliv Rev 2009;61:554-71.
16. Stoff-Khalili MA, Rivera AA, Nedeljkovic-Kurepa A, De-Benedetti A, Li XL, et al. Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational control. Breast Cancer Res Treat 2008;108:43-55.
17. Ueda K, Iwahashi M, Matsuura I, Nakamori M, Nakamura M, et al. Adenoviral-mediated gene transduction of the hepa-tocyte growth factor (HGF) antagonist, NK4, suppresses peritoneal metastases of gastric cancer in nude mice. Eur J Cancer 2004;40:2135-42.
18. Nakabayashi M, Morishita R, Nakagami H, Kuba K, Mat-sumoto K, et al. HGF/NK4 inhibited VEGF-induced ang-iogenesis in in vitro cultured endothelial cells and in vivo rabbit model. Diabetologia 2003;46:115-23.